The analysis lead to the identification of TIMP-1, FN-1, SPARC, IGFBP-3, LGALS3BP, and GREM1 (Fig. 1A) as the most upregulated glycoproteins in early-stage pancreatic tumor tissues as compared to controls. This evidence concerns the gene GREM1 and pancreatic neoplasm.